Software for calculation bone density

Institute for Radiological Image Sciences 4/23/97 Software for calculation bone density

During a Food and Drug Administration (FDA) inspection of your firm located in Frederick, Maryland, on March 23 and 26, 1997, our Investigator determined that your firm manufactures the IRIS software program used for calculating bone density, which is a device as defined by Section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act).

1. Failure to maintain a complete Device Master Record (DMR). For example, the DMR did not include approved specifications and procedures for the manufacturing, components, quality assurance, packaging, labeling, and finished product release testing for the IRIS software program [21 CFR 820.181].

2. Failure to document and control changes made to the manufacturing specifications or source code to assure that the device conforms to its original design [21 CFR 820.100(a)(2)]. For example, you did not document the reason for a software upgrade from version 2.03 to 2.04.

3. Failure to maintain Device History Records for the validation and release testing of the finished device [21 CFR 820.160]. For example, no written records were available to show that testing was conducted to insure that the IRIS software program functioned properly prior to distribution.

4. Failure to maintain written procedures to schedule and conduct periodic audits of the quality assurance program [21 CFR 820.20(b)]. For example, there were no audit procedures and no record that audits of the quality assurance program have been performed.

5. Failure to review, evaluate, and investigate complaints and to maintain complaint files [21 CFR 820.198]. For example, you received a complaint from [purged text], however, no records were available to document why an investigation was not required nor was the reply to the complainant documented.

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.